Reference
Yang T, et al. Elevation of tumor mutation burden in ROS1-fusion lung adenocarcinoma resistant to crizotinib: A case report. Medicine 97: e13797, No. 52, Dec 2018. Available from: URL: http://doi.org/10.1097/MD.0000000000013797 - China
Rights and permissions
About this article
Cite this article
Antineoplastics. Reactions Weekly 1739, 36 (2019). https://doi.org/10.1007/s40278-019-57676-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-019-57676-6